Yes According to the headline of today's inquiry, on March 23rd, 2002 1, the national1new lung cancer drug (fumitinib mesylate) patient charity assistance project developed by Shanghai Alice Medical Technology Co., Ltd. was officially launched, and the "Fuyao Xinsheng" patient assistance project initiated by Beijing Meng Kang Charity Foundation was aimed at assisting patients with non-small cell lung cancer who were confirmed to be suitable for Iverson treatment by designated medical institutions. On 20021,Fuyao new-born patient assistance project was launched in 30 provinces, municipalities and autonomous regions of China to provide drug support for patients diagnosed with non-small cell lung cancer.